Tower Research Capital (TRC)’s Petros Pharmaceuticals PTPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | -$1 | – | 5513 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5123 |
|
|
2024
Q4 | – | Sell |
-130
| Closed | -$1.16K | – | 5937 |
|
|
2024
Q3 | $1.16K | Sell |
130
-1
| -0.8% | -$9 | ﹤0.01% | 5195 |
|
|
2024
Q2 | $1.5K | Sell |
131
-5
| -4% | -$57 | ﹤0.01% | 5150 |
|
|
2024
Q1 | $5.03K | Sell |
136
-229
| -63% | -$8.46K | ﹤0.01% | 4594 |
|
|
2023
Q4 | $12.9K | Buy |
365
+263
| +258% | +$9.27K | ﹤0.01% | 4009 |
|
|
2023
Q3 | $4.4K | Hold |
102
| – | – | ﹤0.01% | 4871 |
|
|
2023
Q2 | $5.17K | Buy |
102
+10
| +11% | +$507 | ﹤0.01% | 4830 |
|
|
2023
Q1 | $3K | Buy |
92
+72
| +360% | +$2.35K | ﹤0.01% | 5231 |
|
|
2022
Q4 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 5650 |
|
|
2022
Q2 | – | Sell |
-16
| Closed | -$6K | – | 6437 |
|
|
2022
Q1 | $6K | Buy |
16
+3
| +23% | +$1.13K | ﹤0.01% | 4914 |
|
|
2021
Q4 | $11K | Buy |
+13
| New | +$11K | ﹤0.01% | 4443 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6081 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5762 |
|